Literature DB >> 30216530

Toward 7T breast MRI clinical study: safety assessment using simulation of heterogeneous breast models in RF exposure.

Xin Li1, Joseph V Rispoli1,2,3.   

Abstract

PURPOSE: To facilitate assessment of RF power deposition and temperature rise within the breast, we present a method to seamlessly join heterogeneous breast models with standard whole-body models and demonstrate simulations at 7 T.
METHODS: Finite-difference time-domain electromagnetic and bioheat simulations are performed to analyze the specific absorption rate (SAR) and temperature rise distributions in 36 Breast Imaging Reporting and Data System (BI-RADS) categorized breast models fused to 2 female whole-body models while transmitting from a 7T breast volume coil. The breast models are uncompressed in the prone position and feature heterogeneous tissue contents; fusion with human models uses affine transformation and the level-set method.
RESULTS: The fusion method produces a continuous transient from the chest region to the posterior portion of breast models while preserving the original volume and shape of breast models. Simulation results of both Ella and Hanako models indicate that the maximum local SAR, partial body SAR, and local tissue temperature rise are positively correlated with both breast density and the highest BI-RADS density classification. Additionally, maximum local tissue temperature rise is positively correlated with maximum 10-g SAR values.
CONCLUSION: Fibroglandular tissue content plays an important role in the distribution of SAR and temperature rise within breast tissue. The combined body-breast models preserve the integrity of breast models while concurrently exhibiting the loading of whole-body human models. The procedures presented in this simulation study facilitate safety assessments for breast MRI across the population at both clinical and ultrahigh field strengths.
© 2018 International Society for Magnetic Resonance in Medicine.

Entities:  

Keywords:  FDTD; breast density; high field; safety; specific absorption rate; temperature rise

Mesh:

Year:  2018        PMID: 30216530      PMCID: PMC6380517          DOI: 10.1002/mrm.27395

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  38 in total

1.  Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Authors:  E Senkus; S Kyriakides; S Ohno; F Penault-Llorca; P Poortmans; E Rutgers; S Zackrisson; F Cardoso
Journal:  Ann Oncol       Date:  2015-09       Impact factor: 32.976

2.  MRI for diagnosis of pure ductal carcinoma in situ: a prospective observational study.

Authors:  Christiane K Kuhl; Simone Schrading; Heribert B Bieling; Eva Wardelmann; Claudia C Leutner; Roy Koenig; Walther Kuhn; Hans H Schild
Journal:  Lancet       Date:  2007-08-11       Impact factor: 79.321

Review 3.  Modelling the interaction of electromagnetic fields (10 MHz-10 GHz) with the human body: methods and applications.

Authors:  J W Hand
Journal:  Phys Med Biol       Date:  2008-07-24       Impact factor: 3.609

4.  Analysis of tissue and arterial blood temperatures in the resting human forearm.

Authors:  H H PENNES
Journal:  J Appl Physiol       Date:  1948-08       Impact factor: 3.531

5.  Experimental and numerical analysis of B1(+) field and SAR with a new transmit array design for 7T breast MRI.

Authors:  Junghwan Kim; Narayan Krishnamurthy; Tales Santini; Yujuan Zhao; Tiejun Zhao; Kyongtae Ty Bae; Tamer S Ibrahim
Journal:  J Magn Reson       Date:  2016-04-23       Impact factor: 2.229

Review 6.  Imaging techniques for breast MR imaging.

Authors:  N M Hylton; S D Frankel
Journal:  Magn Reson Imaging Clin N Am       Date:  1994-11       Impact factor: 2.266

Review 7.  ACR Appropriateness Criteria Breast Cancer Screening.

Authors:  Martha B Mainiero; Ana Lourenco; Mary C Mahoney; Mary S Newell; Lisa Bailey; Lora D Barke; Carl D'Orsi; Jennifer A Harvey; Mary K Hayes; Phan Tuong Huynh; Peter M Jokich; Su-Ju Lee; Constance D Lehman; David A Mankoff; Joshua A Nepute; Samir B Patel; Handel E Reynolds; M Linda Sutherland; Bruce G Haffty
Journal:  J Am Coll Radiol       Date:  2013-01       Impact factor: 5.532

Review 8.  MR imaging of the breast for the detection, diagnosis, and staging of breast cancer.

Authors:  S G Orel; M D Schnall
Journal:  Radiology       Date:  2001-07       Impact factor: 11.105

9.  31P MRSI and 1H MRS at 7 T: initial results in human breast cancer.

Authors:  Dennis W J Klomp; Bart L van de Bank; Alexander Raaijmakers; Mies A Korteweg; Cecilia Possanzini; Vincent O Boer; Cornelius A T van de Berg; Maurice A A J van de Bosch; Peter R Luijten
Journal:  NMR Biomed       Date:  2011-03-24       Impact factor: 4.044

Review 10.  Review of imaging techniques for the diagnosis of breast cancer: a new role of prone scintimammography using technetium-99m sestamibi.

Authors:  I Khalkhali; I Mena; L Diggles
Journal:  Eur J Nucl Med       Date:  1994-04
View more
  4 in total

1.  SAR and temperature distributions in a database of realistic human models for 7 T cardiac imaging.

Authors:  Bart R Steensma; Ettore F Meliadò; Peter Luijten; Dennis W J Klomp; Cornelis A T van den Berg; Alexander J E Raaijmakers
Journal:  NMR Biomed       Date:  2021-05-06       Impact factor: 4.044

2.  Electromagnetic simulation of a 16-channel head transceiver at 7 T using circuit-spatial optimization.

Authors:  Xin Li; Jullie W Pan; Nikolai I Avdievich; Hoby P Hetherington; Joseph V Rispoli
Journal:  Magn Reson Med       Date:  2021-02-03       Impact factor: 3.737

Review 3.  Current and Emerging Magnetic Resonance-Based Techniques for Breast Cancer.

Authors:  Apekshya Chhetri; Xin Li; Joseph V Rispoli
Journal:  Front Med (Lausanne)       Date:  2020-05-12

4.  Statistical Evaluation of Radiofrequency Exposure during Magnetic Resonant Imaging: Application of Whole-Body Individual Human Model and Body Motion in the Coil.

Authors:  Wenli Liu; Hongkai Wang; Pu Zhang; Chengwei Li; Jie Sun; Zhaofeng Chen; Shengkui Xing; Ping Liang; Tongning Wu
Journal:  Int J Environ Res Public Health       Date:  2019-03-25       Impact factor: 3.390

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.